Funding
2013 Overall proportion of industry and non-industry
- Industry-related income: 100%
Percentage of the highest contributor: 11,8%
2014 Overall proportion of industry and non-industry
- Industry-related income: 100%
Percentage of the highest contributor: 41%
2015 Overall proportion of industry and non-industry
Industry-related income: 100%
Percentage of the highest contributor: 34%
2016 Overall proportion of industry and non-industry
Industry-related income: 93.71%
Percentage of the highest contributor: 56.71%
2017 Overall proportion of industry and non-industry
Industry-related income: 100%
Percentage of the highest contributor: 41.70%
2018 Overall proportion industry and non-industry
Industry
Core activities: 38,2 %
Projects: 58,9 %
Non industry: 2,9 %
Percentage of the highest contributor: 47 %
2019 Overall proportion industry and non-industry:
Industry
Core activities: 32,4 %
Projects: 48,1 %
Non industry: 19,5 %
Percentage of the overall highest contributor: 50,7 %
2020 Overall proportion industry and non-industry:
Industry funding (from Grünenthal, Boston Scientific and UP John UK Limited): 87%
Non-industry funding (from partner organizations EFIC and EFNA for joint projects and membership fees): 13%
Percentage of total highest contributor:
- For PAE core costs and projects: 45%
- For the grants to be awarded to BMP Grant winners: 34%
2021 Overall proportion industry and non-industry:
Industry funding (from Grünenthal, Pfizer, Janssen, Boston Scientific, Viatris, GSK): 90,9%
Non-industry funding (from partner organisations, e.g., EFIC, EFNA, university educational projects, and membership fees): 9,1%
Percentage of total highest contributor:
- For PAE core costs and projects: 21,25%
- For the grants to be awarded to BMP Grant winners: 78,74%
